Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates

Core Insights - Teladoc (TDOC) reported a quarterly loss of $0.21 per share, better than the Zacks Consensus Estimate of a loss of $0.26, representing an earnings surprise of +19.23% [1] - The company generated revenues of $626.44 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.23%, although this is a decline from $640.51 million in the same quarter last year [2] - Teladoc has outperformed consensus EPS estimates three times over the last four quarters and has topped revenue estimates four times in the same period [2] Financial Performance - The company has shown a favorable trend in estimate revisions ahead of the earnings release, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] - Current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $636.73 million, while for the current fiscal year, the estimate is -$1.17 on revenues of $2.52 billion [7] Market Context - Teladoc shares have declined approximately 8% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] - The Medical Services industry, to which Teladoc belongs, is currently ranked in the top 39% of over 250 Zacks industries, suggesting a favorable industry outlook [8]